Literature DB >> 20935300

Replicon sequence typing of IncF plasmids carrying virulence and resistance determinants.

Laura Villa1, Aurora García-Fernández, Daniela Fortini, Alessandra Carattoli.   

Abstract

OBJECTIVES: IncF plasmids are frequently encountered in clinical enterobacterial strains associated with the dissemination of relevant antimicrobial resistance and virulence genes. These plasmids are usually heterogeneous in size and carry multiple replicons, and technical difficulties can impair the comparison and detection of related plasmids by restriction fragment length polymorphism analysis. We devised a rapid sequence-based typing scheme to categorize the members of this plasmid family into homogeneous groups.
METHODS: We compared the available IncF replicon sequences, identifying the combination of the different IncF replicon alleles as the discriminating characteristic of these plasmid scaffolds. An IncF typing method based on PCR amplification and sequence typing of the IncF replicons was devised. A collection of IncF plasmids carrying resistance and/or virulence genes, identified in strains from different sources and geographical origins, was tested with this typing system.
RESULTS: We devised a replicon sequence typing (RST) scheme discriminating IncF plasmid variants. This system was tested on the collection of IncF plasmids, demonstrating that it was useful for the discrimination of plasmids carrying the same resistance gene (i.e. the bla(CTX-M-15) gene), but also recognized strictly related virulence plasmids (i.e. IncFIme plasmids). The PCR-based replicon typing (PBRT) system was also updated by including new primer pairs to allow the identification of the Salmonella, Klebsiella and Yersinia IncF plasmids.
CONCLUSIONS: The ability to recognize and sub-categorize IncF plasmids by RST in homogeneous groups on the basis of their phylogenetic relatedness can be helpful in analysing their distribution in nature and discovering their evolutionary origin.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20935300     DOI: 10.1093/jac/dkq347

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  219 in total

1.  Molecular characteristics of KPC-producing Enterobacteriaceae at the early stage of their dissemination in Poland, 2008-2009.

Authors:  Anna Baraniak; Anna Grabowska; Radosław Izdebski; Janusz Fiett; Małgorzata Herda; Katarzyna Bojarska; Dorota Żabicka; Marta Kania-Pudło; Grazyna Młynarczyk; Zofia Żak-Puławska; Waleria Hryniewicz; Marek Gniadkowski
Journal:  Antimicrob Agents Chemother       Date:  2011-09-19       Impact factor: 5.191

2.  Characterization of extended-spectrum β-lactamase genes found among Escherichia coli isolates from duck and environmental samples obtained on a duck farm.

Authors:  Junying Ma; Jian-Hua Liu; Luchao Lv; Zhiyong Zong; Yan Sun; Hongqing Zheng; ZhangLiu Chen; Zhen-Ling Zeng
Journal:  Appl Environ Microbiol       Date:  2012-03-09       Impact factor: 4.792

3.  Dissemination of the fosfomycin resistance gene fosA3 with CTX-M β-lactamase genes and rmtB carried on IncFII plasmids among Escherichia coli isolates from pets in China.

Authors:  Jianxia Hou; Xianhui Huang; Yuting Deng; Liangying He; Tong Yang; Zhenling Zeng; Zhangliu Chen; Jian-Hua Liu
Journal:  Antimicrob Agents Chemother       Date:  2012-01-09       Impact factor: 5.191

4.  First detection of blaIMI-2 gene in a clinical Escherichia coli strain.

Authors:  Beatriz Rojo-Bezares; Carmen Martín; María López; Carmen Torres; Yolanda Sáenz
Journal:  Antimicrob Agents Chemother       Date:  2011-11-21       Impact factor: 5.191

5.  Klebsiella pneumoniae ST258 producing KPC-3 identified in italy carries novel plasmids and OmpK36/OmpK35 porin variants.

Authors:  Aurora García-Fernández; Laura Villa; Claudio Carta; Carolina Venditti; Alessandra Giordano; Mario Venditti; Carlo Mancini; Alessandra Carattoli
Journal:  Antimicrob Agents Chemother       Date:  2012-01-17       Impact factor: 5.191

6.  A plasmid-encoded class 1 integron contains GES-type extended-spectrum β-lactamases in Enterobacteriaceae clinical isolates in Mexico.

Authors:  Humberto Barrios; Ulises Garza-Ramos; Luz Edith Ochoa-Sanchez; Fernando Reyna-Flores; Teresa Rojas-Moreno; Rayo Morfin-Otero; Eduardo Rodriguez-Noriega; Elvira Garza-Gonzalez; Gloria Gonzalez; Patricia Volkow; Patricia Cornejo-Juarez; Jesus Silva-Sanchez
Journal:  Antimicrob Agents Chemother       Date:  2012-04-23       Impact factor: 5.191

7.  Characterization of Tn3000, a Transposon Responsible for blaNDM-1 Dissemination among Enterobacteriaceae in Brazil, Nepal, Morocco, and India.

Authors:  Juliana Coutinho Campos; Maria José Félix da Silva; Paulo Roberto Nascimento dos Santos; Elaine Menezes Barros; Mayne de Oliveira Pereira; Bruna Mara Silva Seco; Cibele Massotti Magagnin; Leonardo Kalab Leiroz; Théo Gremen Mimary de Oliveira; Célio de Faria-Júnior; Louise Teixeira Cerdeira; Afonso Luís Barth; Suely Carlos Ferreira Sampaio; Alexandre Prehn Zavascki; Laurent Poirel; Jorge Luiz Mello Sampaio
Journal:  Antimicrob Agents Chemother       Date:  2015-09-21       Impact factor: 5.191

8.  Pediatric carbapenem-resistant Enterobacteriaceae in Los Angeles, California, a high-prevalence region in the United States.

Authors:  Pia S Pannaraj; Jennifer Dien Bard; Chiara Cerini; Scott J Weissman
Journal:  Pediatr Infect Dis J       Date:  2015-01       Impact factor: 2.129

9.  In silico detection and typing of plasmids using PlasmidFinder and plasmid multilocus sequence typing.

Authors:  Alessandra Carattoli; Ea Zankari; Aurora García-Fernández; Mette Voldby Larsen; Ole Lund; Laura Villa; Frank Møller Aarestrup; Henrik Hasman
Journal:  Antimicrob Agents Chemother       Date:  2014-04-28       Impact factor: 5.191

10.  Genome and Plasmid Analysis of blaIMP-4-Carrying Citrobacter freundii B38.

Authors:  Jianhui Xiong; Maxime Déraspe; Naeem Iqbal; Jennifer Ma; Frances B Jamieson; Jessica Wasserscheid; Ken Dewar; Peter M Hawkey; Paul H Roy
Journal:  Antimicrob Agents Chemother       Date:  2016-10-21       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.